Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Stock
Stocks
002399
CNE100000P02
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shenzhen S.E.
2026-10-28
|
5-day change | 1st Jan Change | ||
| 9.210 CNY | +1.66% |
|
-1.29% | -21.88% |
| Market Cap | 12.22B 1.83B 1.65B 1.52B 1.38B 2.57B 175B 2.6B 18.18B 7.24B 91.38B 6.88B 6.74B 290B | P/E 2026 * |
18.4x | P/E 2027 * | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 9.89B 1.48B 1.33B 1.23B 1.11B 2.08B 141B 2.11B 14.71B 5.86B 73.91B 5.57B 5.45B 235B | EV / Sales 2026 * |
1.94x | EV / Sales 2027 * | 2.36x |
| Free-Float |
14.94% | Yield 2026 * |
0.65% | Yield 2027 * | 0.76% |
| 1 day | +1.66% | ||
| 1 week | -1.29% | ||
| Current month | -6.50% | ||
| 1 month | -4.66% | ||
| 3 months | -3.36% | ||
| 6 months | -14.56% | ||
| Current year | -21.88% |
| 1 week | 8.95 |  | 9.42 |
| 1 month | 8.95 | | 10 |
| Current year | 8.5 | | 12.64 |
| 1 year | 8.5 | | 12.68 |
| 3 years | 6.89 | | 14.34 |
| 5 years | 6.89 | | 18.89 |
| 10 years | 6.89 | | 30.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yu Shan
CEO | Chief Executive Officer | 65 | 1998-04-20 |
Tan Li
PRN | Corporate Officer/Principal | 61 | 1998-04-20 |
Juan Chen
DFI | Director of Finance/CFO | 51 | 2023-08-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Tan Li
BRD | Director/Board Member | 61 | 1998-04-20 |
Li Li
CHM | Chairman | 62 | 1998-04-20 |
Yu Shan
BRD | Director/Board Member | 65 | 1998-04-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/23/23 | Sell | 11,200 | 0.0009% | |||
| 5/26/21 | Other | Chief Financial Officer | 459,588 | 0.2088% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.66% | -1.29% | -22.80% | -24.57% | 1.83B | |
| +0.50% | +1.38% | +57.09% | +129.96% | 1,148B | |
| +0.86% | +5.14% | +45.00% | +86.15% | 652B | |
| -0.14% | +0.42% | +25.69% | +105.85% | 505B | |
| +0.56% | +2.19% | +53.88% | +66.06% | 384B | |
| -0.63% | -5.97% | +61.93% | +37.06% | 348B | |
| +2.89% | +2.90% | +34.64% | +56.71% | 294B | |
| +1.18% | -0.66% | +2.66% | +26.19% | 264B | |
| +0.87% | +3.08% | +54.69% | +72.74% | 244B | |
| +0.08% | +3.67% | +35.05% | +107.78% | 197B | |
| Average | +1.27% | +1.32% | +34.78% | +66.39% | 403.9B | |
| Weighted average by Cap. | +1.29% | +1.50% | +44.87% | +89.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.1B 766M 687M 635M 575M 1.07B 72.91B 1.09B 7.59B 3.02B 38.15B 2.87B 2.81B 121B | 5.62B 842M 756M 699M 633M 1.18B 80.23B 1.2B 8.35B 3.33B 41.98B 3.16B 3.09B 133B |
| Net income | 731M 110M 98.31M 90.9M 82.32M 154M 10.44B 156M 1.09B 433M 5.46B 411M 403M 17.34B | 874M 131M 118M 109M 98.46M 184M 12.48B 186M 1.3B 518M 6.53B 492M 481M 20.74B |
| Net Debt | -2.34B -351M -315M -291M -263M -492M -33.39B -498M -3.48B -1.38B -17.47B -1.32B -1.29B -55.46B | 1B 151M 135M 125M 113M 211M 14.34B 214M 1.49B 595M 7.5B 565M 553M 23.82B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | CN¥9.210 | +1.66% | 3,028,400 |
| 26-10-27 | CN¥9.060 | -3.10% | 2,845,800 |
| 26-10-26 | CN¥9.350 | +0.86% | 3,079,900 |
| 26-10-23 | CN¥9.270 | +1.42% | 3,102,200 |
| 26-10-22 | CN¥9.140 | -2.04% | 2,519,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 002399 Stock
Select your edition
All financial news and data tailored to specific country editions
